Approvals/TGA/IRPRESTAN HCT 300/12.5 irbesartan hydrochlorothiazide 300/12.5 mg tablets blister pack

Approved

STANDARD

IRPRESTAN HCT 300/12.5 irbesartan hydrochlorothiazide 300/12.5 mg tablets blister pack

Medis Pharma Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: edb0ca4e3a3310ce
Product Name: IRPRESTAN HCT 300/12.5 irbesartan hydrochlorothiazide 300/12.5 mg tablets blister pack
Artg Id: 189381
Artg Name: IRPRESTAN HCT 300/12.5 irbesartan hydrochlorothiazide 300/12.5 mg tablets blister pack
Sponsor: Medis Pharma Pty Ltd
Company Detail Path: /organization/medis-pharma-pty-ltd
Artg Date: 2013-03-22
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

edb0ca4e3a3310ce

Type

Standard